Sana Biotechnology Statistics
NASDAQ: SANAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.790.00 (0.00%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Sana Biotechnology by the numbers
Sana Biotechnology has a market capitalization of $835.2 million based on 299.36M shares outstanding. With trailing EPS of $-0.76, Sana Biotechnology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 17.8% below its 50-day average and 21.4% below its 200-day average.
Average daily trading volume is 3.13M shares, or about $8.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SANA valuation vs. peer median
| Metric | SANA | Peer median | Difference |
|---|---|---|---|
| Market cap | $835.22M | $803.67M | +4% |
| Avg. volume | 3.13M | 1.01M | +210% |
Peer median across 8 companies: SLBT, DNA, GLUE, CADL, ODTX, ATTO, SLDB, FDMT.
Valuation
- Market cap
- $835.22M
- EPS (TTM)
- $-0.76
- Shares outstanding
- 299.36M
Price and trading
- Previous close
- 2.79
- Open
- 2.79
- Day range
- 2.77 – 2.87
- 52-week range
- 2.61 – 6.55
- 52-week change
- -38.41%
- Beta
- —
- Volume
- 2.92M
- Average volume
- 3.13M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 835.22M
- Forward Pe
- -5.03
- Eps
- -0.76
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.55
- Week52 Low
- 2.61
- Avg Volume
- 3.13M
- Shares Outstanding
- 299.36M
- Ma50
- 3.39
- Ma200
- 3.55
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -57.40%
- Pct From52w Low
- 6.90%